From: Fabrication of 6-gingerol, doxorubicin and alginate hydroxyapatite into a bio-compatible formulation: enhanced anti-proliferative effect on breast and liver cancer cells
System
DL (%)
EE (%)
6-Gin-m-HAP system
3.77 ± 0.55
98.8 ± 0.05
Dox-m-HAP system
23.0 ± 0.33
97.4 ± 0.12
6-Gin + Dox-m-HAP system
20.0 ± 0.12
81.9 ± 0.32